Abstract:Molecular imaging includes proteomic, metabolic, cellular biologic process, and genetic imaging. In a narrow sense, molecular imaging means genetic imaging and can be called molecular-genetic imaging. Imaging reporter genes play a leading role in molecular-genetic imaging. There are 3 major methods of molecular-genetic imaging, based on optical, MRI, and nuclear medicine modalities. For each of these modalities, various reporter genes and probes have been developed, and these have resulted in successful transitions from bench to bedside applications. Each of these imaging modalities has its unique advantages and disadvantages. Fluorescent and bioluminescent optical imaging modalities are simple, less expensive, more convenient, and more user friendly than other imaging modalities. Another advantage, especially of bioluminescence imaging, is its ability to detect low levels of gene expression. MRI has the advantage of high spatial resolution, whereas nuclear medicine methods are highly sensitive and allow data from small-animal imaging studies to be translated to clinical practice. Moreover, multimodality imaging reporter genes will allow us to choose the imaging technologies that are most appropriate for the biologic problem at hand and facilitate the clinical application of reporter gene technologies. Reporter genes can be used to visualize the levels of expression of particular exogenous and endogenous genes and several intracellular biologic phenomena, including specific signal transduction pathways, nuclear receptor activities, and protein-protein interactions. This technique provides a straightforward means of monitoring tumor mass and can visualize the in vivo distributions of target cells, such as immune cells and stem cells. Molecular imaging has gradually evolved into an important tool for drug discovery and development, and transgenic mice with an imaging reporter gene can be useful during drug and stem cell therapy development. Moreover, instrumentation improvements, the identification of novel targets and genes, and imaging probe developments suggest that molecular-genetic imaging is likely to play an increasingly important role in the diagnosis and therapy of cancer.

Optical Molecular Imaging Technology in Genetically Engineered Mouse Models

Non-Invasive Optical Imaging of Tumor Growth in Intact Animals

Genetically engineered mouse models in oncology research and cancer medicine

New optical molecular imaging systems.

Use Of The Odd-Luciferase Transgene For The Non-Invasive Imaging Of Spontaneous Tumors In Mice

Molecular-genetic imaging based on reporter gene expression

Molecular Imaging of Tumor Angiogenesis and Therapeutic Effects with Dual Bioluminescence

In Vivo Quantitative Bioluminescence Tomography Using Heterogeneous and Homogeneous Mouse Models

Compact Whole-Body Fluorescent Imaging of Nude Mice Bearing Egfp Expressing Tumor

New in vivo optical molecular imaging modalities

[Application and Recent Advances of Laboratory Mouse in Human Cancer Research].

Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models

Optical Molecular Imaging in Drug Discovery and Clinical Development

SEMMs: Somatically Engineered Mouse Models. A New Tool for In Vivo Disease Modeling for Basic and Translational Research

Optical molecular imaging for systems biology: from molecule to organism

Application of Optical Molecular Imaging for the Development of Anticancer Drugs

Opticool: Cutting-edge transgenic optical tools

A Magneto-Optical Nanoplatform for Multimodality Imaging of Tumors in Mice.

In Vivo Fluorescence Reflectance Imaging with Subcutaneous Mouse Tumor Models.

Optical Molecular Imaging for Early Tumor Diagnosis and Drug Development

Visualization of GFP-expressing tumors and metastasis in vivo